LEADER 01397nam 2200397 a 450 001 9910698819603321 005 20090601091601.0 035 $a(CKB)5470000002397673 035 $a(OCoLC)367582071 035 $a(EXLCZ)995470000002397673 100 $a20090601d2009 ua 0 101 0 $aeng 135 $aurmn||||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aRyan White Care Act$b[electronic resource] $eimplementation of the new Minority AIDS Initiative provisions : report to congressional committees 210 1$a[Washington, D.C.] :$cU.S. Govt. Accountability Office,$d[2009] 215 $aiii, 51 pages $cdigital, PDF file 300 $aTitle from title screen (viewed on May 28, 2009). 300 $a"March 2009." 300 $a"GAO-09-315." 320 $aIncludes bibliographical references. 517 $aRyan White Care Act 606 $aMinorities$xMedical care$zUnited States$xFinance 606 $aHIV-positive persons$xMedical care$xFinance 606 $aAIDS (Disease)$xTreatment$xFinance 615 0$aMinorities$xMedical care$xFinance. 615 0$aHIV-positive persons$xMedical care$xFinance. 615 0$aAIDS (Disease)$xTreatment$xFinance. 801 0$bGPO 801 1$bGPO 906 $aBOOK 912 $a9910698819603321 996 $aRyan White Care Act$93426227 997 $aUNINA LEADER 03776nam 2200505 450 001 9910816262403321 005 20230616221822.0 010 $a0-309-45007-1 010 $a0-309-45009-8 035 $a(CKB)3710000001084893 035 $a(MiAaPQ)EBC4833787 035 $a(EXLCZ)993710000001084893 100 $a20170419h20162016 uy 0 101 0 $aeng 135 $aurcnu|||||||| 181 $2rdacontent 182 $2rdamedia 183 $2rdacarrier 200 14$aThe ebola epidemic in West Africa $eproceedings of a workshop /$fNational Academies of Sciences, Engineering, and Medicine (U.S.) ; Allison Mack, Megan Reeve Snair, and Carmen Mundaca-Shah, rapporteurs 210 1$aWashington, District of Columbia :$cThe National Academies Press,$d2016. 210 4$dİ2016 215 $a1 online resource (120 pages) 311 $a0-309-45006-3 327 $aIntroduction -- The outbreak -- Global preparedness and response efforts -- Current and future research opportunities -- Appendix A: References -- Appendix B: Ebola: a view from the National Institute of Allergy and Infectious Diseases -- Appendix C: Ebola virus disease preparedness in Germany: expertise focused in specialized laboratories, competence, and treatment centers -- Appendix D: Statement of task -- Appendix E: Workshop agenda -- Appendix F: Speaker biographies. 330 1 $a"The most recent Ebola epidemic that began in late 2013 alerted the entire world to the gaps in infectious disease emergency preparedness and response. The regional outbreak that progressed to a significant public health emergency of international concern (PHEIC) in a matter of months killed 11,310 and infected more than 28,616. While this outbreak bears some unique distinctions to past outbreaks, many characteristics remain the same and contributed to tragic loss of human life and unnecessary expenditure of capital: insufficient knowledge of the disease, its reservoirs, and its transmission; delayed prevention efforts and treatment; poor control of the disease in hospital settings; and inadequate community and international responses. Recognizing the opportunity to learn from the countless lessons of this epidemic, the National Academies of Sciences, Engineering, and Medicine convened a workshop in March 2015 to discuss the challenges to successful outbreak responses at the scientific, clinical, and global health levels. Workshop participants explored the epidemic from multiple perspectives, identified important questions about Ebola that remained unanswered, and sought to apply this understanding to the broad challenges posed by Ebola and other emerging pathogens, to prevent the international community from being taken by surprise once again in the face of these threats. This publication summarizes the presentations and discussions from the workshop"--$cPublisher's description. 606 $aEbola virus disease$zAfrica, West 606 $aCommunicable diseases$xResearch 607 $aAfrica, Western 607 $aAfrica, West$2fast 615 0$aEbola virus disease 615 0$aCommunicable diseases$xResearch. 676 $a362.19692 702 $aMack$b Alison 702 $aSnair$b Megan Reeve 702 $aMundaca-Shah$b Carmen 712 02$aNational Academies of Sciences, Engineering, and Medicine (U.S.).$bForum on Microbial Threats. 712 02$aNational Academies of Sciences, Engineering, and Medicine (U.S.).$bBoard on Global Health. 712 02$aNational Academies of Sciences, Engineering, and Medicine (U.S.).$bHealth and Medicine Division. 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910816262403321 996 $aThe ebola epidemic in West Africa$94044056 997 $aUNINA LEADER 02246oam 2200637zu 450 001 9910693953703321 005 20251017110058.0 035 $a(CKB)3450000000002068 035 $a(SSID)ssj0000621029 035 $a(PQKBManifestationID)11429386 035 $a(PQKBTitleCode)TC0000621029 035 $a(PQKBWorkID)10613359 035 $a(PQKB)21234695 035 $a(WaSeSS)Innodata00030822 035 $a(GPO)apn2005-011354 035 $a(OCoLC)60656734 035 $a(DNLM)1254805 035 $a(EXLCZ)993450000000002068 100 $a20160829d2005 uy 101 0 $aeng 135 $aur||||||||||| 181 $ctxt 182 $cc 183 $acr 200 00$aKnowledge and access to information on recruitment of underrepresented populations to cancer clinical trials 210 31$a[Place of publication not identified]$cJohns Hopkins University$d2005 215 $a1 online resource 225 1 $aEvidence Reports/Technology Assessments ;$vno. 122 225 1 $aAHRQ publication ;$vno. 05-E019-2 300 $aBibliographic Level Mode of Issuance: Monograph 320 $aIncludes bibliographical references. 410 0$aEvidence report/technology assessment ;$vno. 122. 410 0$aAHRQ publication ;$vno. 05-E019-2. 606 $aNeoplasms 606 $aHealth Services Accessibility 606 $aClinical Trials as Topic 606 $aHealth Services Accessibility 606 $aPatient Participation 606 $aPatient Selection 607 $aUnited States 615 12$aNeoplasms. 615 22$aHealth Services Accessibility. 615 22$aClinical Trials as Topic. 615 22$aHealth Services Accessibility. 615 22$aPatient Participation. 615 22$aPatient Selection. 676 $a616.99/40072 701 $aFord$b Jean G$01351638 712 02$aJohns Hopkins Bloomberg School of Public Health, 712 02$aJohns Hopkins University Evidence-based Practice Center 712 02$aUnited States Agency for Healthcare Research and Quality 801 0$bPQKB 906 $aBOOK 912 $a9910693953703321 996 $aKnowledge and access to information on recruitment of underrepresented populations to cancer clinical trials$93124914 997 $aUNINA